DataMeds AI, Inc.
MEDSNasdaqCIK 2030763Consumer discretionaryFiscal year ends Dec 31
Reports and events: 88 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2617:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-048573 |
| 2026-10-2009:24 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-047711 |
| 2026-10-1617:15 ET | 8-K | 1.01 Entry into a material agreement; 3.01 Delisting notice; 3.02 Unregistered sale of equity | 0001493152-26-047451 |
| 2026-10-1317:27 ET | 8-K | 8.01 Other events | 0001493152-26-046887 |
| 2026-10-0917:20 ET | S-1/A | Registration statement, amended | 0001493152-26-046608 |
| 2026-09-1717:23 ET | 8-K | 8.01 Other events | 0001493152-26-043169 |
| 2026-09-1617:11 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042951 |
| 2026-08-1807:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-038891 |
| 2026-08-1706:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-038581 |
| 2026-08-1416:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-038475 |
| 2026-08-0717:23 ET | S-1 | Registration statement | 0001493152-26-036665 |
| 2026-08-0416:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-036005 |
| 2026-07-2919:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-035058 |
| 2026-07-2116:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-034086 |
| 2026-06-1216:32 ET | 8-K | 3.01 Delisting notice; 8.01 Other events | 0001493152-26-028464 |
| 2026-06-0316:15 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-26-027063 |
| 2026-06-0216:15 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-26-026879 |
| 2026-05-2917:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-026452 |
| 2026-05-2116:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-024823 |
| 2026-05-2106:51 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-024723 |
| 2026-05-1917:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-024454 |
| 2026-05-1916:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-024413 |
| 2026-05-1906:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-024324 |
| 2026-05-1807:20 ET | 8-K | 8.01 Other events | 0001493152-26-024058 |
| 2026-05-0716:13 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-021718 |
| 2026-05-0416:05 ET | 8-K/A | 1.01 Entry into a material agreement | 0001493152-26-021102 |
| 2026-05-0416:05 ET | DEF 14A | Proxy statementPeriod 2026-05-04 | 0001493152-26-021106 |
| 2026-04-2417:03 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001493152-26-018958 |
| 2026-04-2116:46 ET | 8-K/A | 1.01 Entry into a material agreement; 3.01 Delisting notice; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-018326 |
| 2026-04-1716:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-017895 |
| 2026-04-0916:35 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events | 0001493152-26-015898 |
| 2026-04-0716:42 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-015548 |
| 2026-03-2017:27 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-012004 |
| 2026-03-1117:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009702 |
| 2026-03-0917:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009384 |
| 2026-02-1317:27 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-006815 |
| 2026-02-0917:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-005819 |
| 2026-02-0517:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-005387 |
| 2026-01-2006:04 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-002690 |
| 2026-01-0817:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-001001 |
| 2025-12-1916:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-028571 |
| 2025-12-1620:33 ET | 8-K | 3.01 Delisting notice | 0001493152-25-027830 |
| 2025-12-0816:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-026652 |
| 2025-12-0516:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-026358 |
| 2025-11-2616:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025169 |
| 2025-11-2609:23 ET | 8-K/A | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025072 |
| 2025-11-2517:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-024999 |
| 2025-11-2016:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-024471 |
| 2025-11-1917:23 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-024328 |
| 2025-11-1717:20 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-25-023918 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.